![Thomas Beetham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Beetham
Chief Operating Officer at
VIRIDIAN THERAPEUTICS, INC.
Net worth: 235 421 $ as of 2026-05-30
Profile
Thomas W.
Beetham was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the titles held included Secretary, Chief Legal Officer & EVP-Operations from 2019 to 2021.
The current job is Chief Operating Officer at Viridian Therapeutics, Inc., starting in 2023.
Former jobs include Attorney at Palmer & Dodge LLP from 1999 to 2004, Attorney at Genzyme Corp.
from 2004 to 2011, General Legal Counsel at New England Biolabs, Inc. from 2011 to 2013, Chief Legal Officer, Senior VP & General Counsel at Synageva BioPharma Corp.
from 2013 to 2015, Secretary & Chief Legal Officer at Dianthus Therapeutics, Inc. from 2021 to 2023, and Chief Legal Officer at Magenta Therapeutics, Inc. from 2021 to 2023.
Education includes undergraduate studies at Rochester Christian University, graduate studies at Boston College Law School, and an MBA from Wallace E Carroll School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 13,361 ( 0.01% ) | 235 421 $ | 2026-05-30 |
Thomas Beetham active positions
| Companies | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Chief Operating Officer | 2023-10-29 |
Former positions of Thomas Beetham
| Companies | Position | End |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | General Counsel | 2023-08-31 |
| MAGENTA THERAPEUTICS | General Counsel | 2023-08-31 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Founder | 2021-05-31 |
| SYNAGEVA BIOPHARMA CORP | General Counsel | 2015-05-31 |
New England Biolabs, Inc.
 New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries Produces and supplies reagents for the life science industry | General Counsel | 2013-09-30 |
Training of Thomas Beetham
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Palmer & Dodge LLP
 Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries Produces and supplies reagents for the life science industry | Process Industries |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
 Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Thomas Beetham
